A single arm, multicentre, open-label phase II study of orally administered lapatinib (GW572016) as single-agent, second-line treatment of patients with locally advanced or metastatic transitional cell carcinoma

Title:: A single arm, multicentre, open-label phase II study of orally administered lapatinib (GW572016) as single-agent, second-line treatment of patients with locally advanced or metastatic transitional cell carcinoma
Document type:: Meeting Abstract
Author(s):: Grimm, MO; Machiels, JP; Wülfing, C; Richel, D; Treiber, U; de Groot, M; Beuzeboc, P; Farrell, J; Colman, J; El-Hariry, I
Journal title abbreviation:: Ann Oncol
Year:: 2005
Journal volume:: 16 Suppl.
Pages contribution:: 41-41
Language:: eng
Print-ISSN:: 0923-7534
TUM Institution:: Urologische Klinik und Poliklinik
BibTeX

Occurrences: